drugset / Trial / NCT06651541

Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder

NCT06651541

Phase 2 Not yet recruiting 174 enrolled Biozeus Biopharmaceutical S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluation of the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder

Timeline

Start
2026-07-01
Primary completion
2027-06-30
Completion
2027-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject BZ371A Unknown 0.5 ml
Subject BZ371A Unknown 1 ml